DEF 14AThe Ballot
Viking Therapeutics, Inc. files DEF 14A
Filed Apr 12, 2016 · 10y ago · Accession 0001564590-16-016103
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- DEF 14A
- Filing date
- Apr 12, 2016
- Report date
- May 26, 2016
- Document
- vktx-def14a_20160526.htm
- Size
- 1009 KB